Vyome Holdings, Inc. (HIND) is a Healthcare stock trading at $2.30 (as of 2026-08-21), with a market capitalization of $16.14M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Vyome Holdings, Inc. is a clinical-stage healthcare company developing therapeutic products for immuno-inflammatory and rare diseases. Its programs are intended for patients in the United States and other global markets, and the company is based in Princeton, New Jersey.
Vyome Holdings is a clinical-stage healthcare company developing therapeutic products for immuno-inflammatory and rare diseases, with potential commercialization from the United States and global markets.
As a clinical-stage developer of therapeutic products, its path to profits depends on advancing and successfully commercializing its immuno-inflammatory and rare-disease treatments.
Business quality (Weak): The business model is understandable (clinical development aimed at therapies), but the provided financial snapshot shows a very large operating loss and revenue contraction, and there is no official segment breakdown in the data provided.
| Price | $2.30 |
| Market Cap | $16.14M |
| Price / Book | 2.21 |
| Price / Sales | 129.39 |
| Revenue (TTM) | $319714.00 |
| Net Margin | -3209.7% |
| Revenue Growth (YoY) | -96.0% |
| EPS Growth (YoY) | -64.9% |
| Altman Z-Score | -20.09 (distress) |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Top Institutional Holder | MILLENNIUM MANAGEMENT LLC ($155295.00) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Pharmaceutical Products |
| CEO | Venkateswarlu Nelabhotla |
| Employees | 18 |
| Country | US |
| IPO Date | 2016-10-06 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.